معرفی
Didier Jutras-Aswad is a Full Professor (Professeur titulaire) in the Department of Psychiatry and Addictology at the Université de Montréal's Faculty of Medicine. He also serves as a clinical researcher at the Centre hospitalier de l'Université de Montréal (CHUM) and chairs the board of the Grand Chemin, a nonprofit focused on addiction recovery. His work bridges neurobiology and clinical practice, with a focus on the endocannabinoid system's role in addiction and the development of evidence-based interventions for substance use disorders.
Education & Affiliations
- Université de Montréal - Faculty of Medicine
- CHUM Research Centre (CRCHUM)
- Réseau québécois sur le suicide, les troubles de l'humeur et les troubles associés (RQSHA)
- Canadian Institutes of Health Research (CIHR) networks
Research Interests
Dr. Jutras-Aswad's research spans neurobiological mechanisms of addiction, clinical trials for substance dependence treatments, and policy analysis around cannabis legalization. He leads studies on:
- Endocannabinoid system modulation for cocaine dependence
- Cannabis harm reduction strategies for youth with psychosis
- Pharmacogenetic influences on opioid agonist therapy outcomes
- Public health impacts of Canada's cannabis legalization
Grants & Collaborations
He has secured over CAD 15 million in funding from agencies like:
- Fonds de recherche du Québec - Santé (FRQS)
- Canadian Institutes of Health Research (CIHR)
- Ministère de la Santé et des Services sociaux (MSSS)
Notable projects include the OPTIMA trial comparing methadone and buprenorphine/naloxone, and the development of the iCanChange mobile app for cannabis use disorder.
Lab & Teaching
He directs the Addiction Psychiatry Research Unit (URPT) at CHUM, training over 20 graduate students since 2014. His lab employs a multidisciplinary team to advance translational research in addiction medicine.
